Huan Wang

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Gang Jin · 3 shared papers, 2026 · strength 0.82
   • Paper Early-Onset Pancreatic Ductal Adenocarcinoma: Clinical Features, Genomic Landscape, and Treatment-Mediated Survival Adv… DOI 10.21203/rs.3.rs-9647757/v1↗
   • Paper ARNTL2 promotes metastatic phenotypes through SERPINE1 transcription in KRAS G12D pancreatic cancer. DOI 10.1016/j.isci.2026.117479↗
   • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
2. Xiaoyi Yin · 2 shared papers, 2026 · strength 0.55
   • Paper Early-Onset Pancreatic Ductal Adenocarcinoma: Clinical Features, Genomic Landscape, and Treatment-Mediated Survival Adv… DOI 10.21203/rs.3.rs-9647757/v1↗
   • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
3. Kailian Zheng · 2 shared papers, 2026 · strength 0.47
   • Paper ARNTL2 promotes metastatic phenotypes through SERPINE1 transcription in KRAS G12D pancreatic cancer. DOI 10.1016/j.isci.2026.117479↗
   • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
4. Xiaohan Shi · 2 shared papers, 2026 · strength 0.47
   • Paper ARNTL2 promotes metastatic phenotypes through SERPINE1 transcription in KRAS G12D pancreatic cancer. DOI 10.1016/j.isci.2026.117479↗
   • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
5. Guoxiao Zhang · 1 shared paper, 2026 · strength 0.36
   • Paper Early-Onset Pancreatic Ductal Adenocarcinoma: Clinical Features, Genomic Landscape, and Treatment-Mediated Survival Adv… DOI 10.21203/rs.3.rs-9647757/v1↗
6. Xiaoyi Yin · 1 shared paper, 2026 · strength 0.27
   • Paper ARNTL2 promotes metastatic phenotypes through SERPINE1 transcription in KRAS G12D pancreatic cancer. DOI 10.1016/j.isci.2026.117479↗
7. Suizhi Gao · 1 shared paper, 2026 · strength 0.27
   • Paper ARNTL2 promotes metastatic phenotypes through SERPINE1 transcription in KRAS G12D pancreatic cancer. DOI 10.1016/j.isci.2026.117479↗
8. Shiwei Guo · 1 shared paper, 2026 · strength 0.27
   • Paper ARNTL2 promotes metastatic phenotypes through SERPINE1 transcription in KRAS G12D pancreatic cancer. DOI 10.1016/j.isci.2026.117479↗
9. Yehan Zhang · 1 shared paper, 2026 · strength 0.20
   • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
10. Meilong Shi · 1 shared paper, 2026 · strength 0.20
    • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
11. Lingyu Zhu · 1 shared paper, 2026 · strength 0.20
    • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
12. Xiongfei Xu · 1 shared paper, 2026 · strength 0.20
    • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
13. Yunguang Li · 1 shared paper, 2026 · strength 0.20
    • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.